Cargando…

Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction

Celiac disease (CeD) is a T-cell-dependent enteropathy with autoimmune features where tissue transglutaminase (TG2)-mediated posttranslational modification of gliadin peptides has a decisive role in the pathomechanism. The humoral immune response is reported to target mainly TG2-deamidated γ-gliadin...

Descripción completa

Detalles Bibliográficos
Autores principales: Diós, Ádám, Elek, Rita, Szabó, Ildikó, Horváth, Szilvia, Gyimesi, Judit, Király, Róbert, Werkstetter, Katharina, Koletzko, Sibylle, Fésüs, László, Korponay-Szabó, Ilma R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241804/
https://www.ncbi.nlm.nih.gov/pubmed/34059947
http://dx.doi.org/10.1007/s00726-021-03006-7
_version_ 1783715491783639040
author Diós, Ádám
Elek, Rita
Szabó, Ildikó
Horváth, Szilvia
Gyimesi, Judit
Király, Róbert
Werkstetter, Katharina
Koletzko, Sibylle
Fésüs, László
Korponay-Szabó, Ilma R.
author_facet Diós, Ádám
Elek, Rita
Szabó, Ildikó
Horváth, Szilvia
Gyimesi, Judit
Király, Róbert
Werkstetter, Katharina
Koletzko, Sibylle
Fésüs, László
Korponay-Szabó, Ilma R.
author_sort Diós, Ádám
collection PubMed
description Celiac disease (CeD) is a T-cell-dependent enteropathy with autoimmune features where tissue transglutaminase (TG2)-mediated posttranslational modification of gliadin peptides has a decisive role in the pathomechanism. The humoral immune response is reported to target mainly TG2-deamidated γ-gliadin peptides. However, α-gliadin peptides, like p57-68, playing a crucial role in the T-cell response, and p31-43, a major trigger of innate responses, also contain B-cell gliadin epitopes and γ-gliadin like motifs. We aimed to identify if there are anti-gliadin-specific antibodies in CeD patients targeting the p31-43 and p57-68 peptides and to examine whether deamidation of these peptides could increase their antigenicity. We explored TG2-mediated deamidation of the p31-43 and p57-68 peptides, and investigated serum antibody reactivity toward the native and deamidated α and γ-gliadin peptides in children with confirmed CeD and in prospectively followed infants at increased risk for developing CeD. We affinity-purified antibody populations utilizing different single peptide gliadin antigens and tested their binding preferences for cross-reactivity in real-time interaction assays based on bio-layer interferometry. Our results demonstrate that there is serum reactivity toward p31-43 and p57-68 peptides, which is due to cross-reactive γ-gliadin specific antibodies. These γ-gliadin specific antibodies represent the first appearing antibody population in infancy and they dominate the serum reactivity of CeD patients even later on and without preference for deamidation. However, for the homologous epitope sequences in α-gliadins shorter than the core QPEQPFP heptapeptide, deamidation facilitates antibody recognition. These findings reveal the presence of cross-reactive antibodies in CeD patients recognizing the disease-relevant α-gliadins. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00726-021-03006-7.
format Online
Article
Text
id pubmed-8241804
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-82418042021-07-14 Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction Diós, Ádám Elek, Rita Szabó, Ildikó Horváth, Szilvia Gyimesi, Judit Király, Róbert Werkstetter, Katharina Koletzko, Sibylle Fésüs, László Korponay-Szabó, Ilma R. Amino Acids Original Article Celiac disease (CeD) is a T-cell-dependent enteropathy with autoimmune features where tissue transglutaminase (TG2)-mediated posttranslational modification of gliadin peptides has a decisive role in the pathomechanism. The humoral immune response is reported to target mainly TG2-deamidated γ-gliadin peptides. However, α-gliadin peptides, like p57-68, playing a crucial role in the T-cell response, and p31-43, a major trigger of innate responses, also contain B-cell gliadin epitopes and γ-gliadin like motifs. We aimed to identify if there are anti-gliadin-specific antibodies in CeD patients targeting the p31-43 and p57-68 peptides and to examine whether deamidation of these peptides could increase their antigenicity. We explored TG2-mediated deamidation of the p31-43 and p57-68 peptides, and investigated serum antibody reactivity toward the native and deamidated α and γ-gliadin peptides in children with confirmed CeD and in prospectively followed infants at increased risk for developing CeD. We affinity-purified antibody populations utilizing different single peptide gliadin antigens and tested their binding preferences for cross-reactivity in real-time interaction assays based on bio-layer interferometry. Our results demonstrate that there is serum reactivity toward p31-43 and p57-68 peptides, which is due to cross-reactive γ-gliadin specific antibodies. These γ-gliadin specific antibodies represent the first appearing antibody population in infancy and they dominate the serum reactivity of CeD patients even later on and without preference for deamidation. However, for the homologous epitope sequences in α-gliadins shorter than the core QPEQPFP heptapeptide, deamidation facilitates antibody recognition. These findings reveal the presence of cross-reactive antibodies in CeD patients recognizing the disease-relevant α-gliadins. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00726-021-03006-7. Springer Vienna 2021-05-31 2021 /pmc/articles/PMC8241804/ /pubmed/34059947 http://dx.doi.org/10.1007/s00726-021-03006-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Diós, Ádám
Elek, Rita
Szabó, Ildikó
Horváth, Szilvia
Gyimesi, Judit
Király, Róbert
Werkstetter, Katharina
Koletzko, Sibylle
Fésüs, László
Korponay-Szabó, Ilma R.
Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction
title Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction
title_full Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction
title_fullStr Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction
title_full_unstemmed Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction
title_short Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction
title_sort gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241804/
https://www.ncbi.nlm.nih.gov/pubmed/34059947
http://dx.doi.org/10.1007/s00726-021-03006-7
work_keys_str_mv AT diosadam gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction
AT elekrita gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction
AT szaboildiko gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction
AT horvathszilvia gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction
AT gyimesijudit gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction
AT kiralyrobert gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction
AT werkstetterkatharina gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction
AT koletzkosibylle gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction
AT fesuslaszlo gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction
AT korponayszaboilmar gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction